<DOC>
	<DOCNO>NCT01212510</DOCNO>
	<brief_summary>The primary purpose study confirm result previous study usefulness serum Carcinoembryonic antigen ( CEA ) kinetic chemotherapy monitoring patient unresectable metastasis colorectal cancer ( J Clin Oncol 2008 ; 26:3681-6 ) . The secondary purpose evaluate value circulate free mutant DNA circulate tumor cell ( CTC ) variation treatment .</brief_summary>
	<brief_title>Study Circulating Markers Serum Patients Treated Metastatic Colorectal Cancer</brief_title>
	<detailed_description>Prospective cohort study patient treat systemic chemotherapy unresectable metastatic colorectal cancer . The chemotherapy monitor currently base radiological evaluation ( RECIST criterion ) clinical evaluation . Circulating marker CEA , free mutant DNA , CTC represent alternative approach . A previous study usefulness serum Carcinoembryonic antigen ( CEA ) kinetic chemotherapy monitoring patient unresectable metastasis colorectal cancer publish ( J Clin Oncol 2008 ; 26:3681-6 ) . The present study design validate previous data . The secondary purpose evaluate variation free mutant DNA CTC chemotherapy . Patients include prospectively 4 center Normandy . All systemic chemotherapy biotherapy validate clinical situation French National Cancer Institute ( INCa ) accept . Evaluation response base RECIST criterion perform every 3 month . Blood sample CEA CA 19-9 level perform every course chemotherapy first 3 month . Blood sample detection free mutant DNA CTC perform day 1 42 chemotherapy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patient Stage IV colorectal adenocarcinoma histologically prove Patient least one measurable lesion Patient performance status 02 WHO performance scale Patient male female , &gt; 18 year age Patient agree participate give write informed consent Patient know psychiatric substance abuse disorder would interfere cooperation requirement study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>metastatic colorectal cancer</keyword>
	<keyword>circulate tumor marker</keyword>
	<keyword>circulate tumor cell</keyword>
	<keyword>circulate tumor DNA</keyword>
	<keyword>marker 's kinetic</keyword>
</DOC>